Knight Therapeutics Inc (GUD) to Post Q1 2019 Earnings of $0.02 Per Share, Cormark Forecasts Fairfield Current
Knight Therapeutics Inc (TSE:GUD) – Equities researchers at Cormark dropped their Q1 2019 earnings per share (EPS) estimates for shares of Knight …